Flarebio Biotech Co.ltd.

Country/Region: China

Company Introduction
Flarebio Biotech Co.Ltd. prides itself for bringing the most innovative, versatile and low cost antibody,gene,elisa kit,Recombinant Protein. With 10 years of experience and expertise over D Protein manufacturing we have successfully captured Australia,Canada,Germany,India,United Kingdom export market share. Our mission is geared towards providing our customer base with a top notch platform located in in Wuhan, China and Hubei, and online globally where buyers can find only best. Flarebio Biotech Co.ltd. is a known as Manufacturer and Exporter of D Protein started our venture with Below US$1 Million initial business capital, and strive to keep up with a customer-centric approach and ensure utmost satisfaction throughout the buying cycle by providing the most trending and durable leather products. A prolonged experience with manufacturers from different industries made us able to recognize all the untapped marking solutions that have been crucial for our clients. With viable knowledge and expertise we have evolved over time and our annual revenue reached Approx 5 Million US Dollar. Our reliability is backed by our legal status as LLC (Limited Liability Corp) company followed by Third Party. In a nut shell, leather products in best quality are offered to our clients since 2005. We boast 15 Years of export history and export value estimating around US$2.5 Million - US$5 Million. For further details contact flarebio andrew.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2005, 2005

Legal Status: Third Party

Ownership: LLC (Limited Liability Corp)

Employees: 201 - 300 People

Factory Size: 30, 000-50, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: ISO/TS16949

Contact Information

Contact Person: flarebio andrew

Designation: President

Department: Administrative

Telephone: 027-87909808

Business Information

Main Markets: Germany (20%) India (20%) Canada (14%) United Kingdom (13%) Australia (10%)

Export Focus: Australia, Canada, Germany, India, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 5 Million US Dollar

Registered Capital: Below US$1 Million

Export Percentage: 41% - 50%

Payment Terms: Bank wire (T/T), Letter of Credit (L/C), MoneyGram, Cash

Product Showcase
antibody
gene
elisa kit
Recombinant Protein
antibody

CL-Link > Health & Medicines in China Health Care Supplement in China D Protein in China